{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:05:18Z","timestamp":1766361918104,"version":"3.45.0"},"reference-count":45,"publisher":"CSIRO Publishing","issue":"3","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":1716,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION<\/jats:title>\n                    <jats:p>The prevalence of cancer in the community is likely to be increasing due to an ageing population, implementation of cancer screening programmes and advances in cancer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIM<\/jats:title>\n                    <jats:p>To determine the prevalence of primary invasive cancers in a large general practice patient population in New Zealand and to characterise the health-care status of these cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Data were sourced from the patient management system of a large general practice (n\u2009=\u200911,374 patients) in a medium-sized Waikato town and from the New Zealand Cancer Registry dataset to identify patients diagnosed with cancer between January 2009 and December 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>There were 206 cancer diagnoses in 201 patients; 35 cancers were diagnosed in 1887 M\u0101ori patients (1.9%) and 171 in 9487 non-M\u0101ori patients (1.8%). The age-standardised prevalence was 3092\/100,000 in M\u0101ori patients and 1971\/100,000 in non-M\u0101ori patients. The most prevalent cancers were breast, male genital organ, digestive organ and skin cancers. In May 2019, 81 of 201 (40.8%) patients with cancer were receiving only usual care from their general practitioner, whereas 66 (32.8%) were having their cancer managed in secondary care. Comorbidities were common, including hypertension (38.8%), gastrointestinal disorders (29.9%) and mood disorders (24.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>Results suggest that there may be disparities in cancer prevalence between M\u0101ori and non-M\u0101ori patients, although this needs to be confirmed in other general practices. Furthermore, primary care appears to be responsible for most of the care in this patient cohort and workloads should be planned accordingly, particularly with the high incidence of comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/hc19113","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T23:45:35Z","timestamp":1599608735000},"page":"215-224","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of invasive cancer in a large general practice patient population in New Zealand"],"prefix":"10.1071","volume":"12","author":[{"given":"Dong Hyun","family":"Kim","sequence":"first","affiliation":[{"name":"ASchool of Medicine, University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Chepulis","sequence":"additional","affiliation":[{"name":"BWaikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawiri","family":"Keenan","sequence":"additional","affiliation":[{"name":"BWaikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhuan","family":"Lao","sequence":"additional","affiliation":[{"name":"BWaikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Hodgson","sequence":"additional","affiliation":[{"name":"CPinnacle Health, Hamilton, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Bullen","sequence":"additional","affiliation":[{"name":"DSchool of Population Health, University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Lawrenson","sequence":"additional","affiliation":[{"name":"BWaikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand"},{"name":"EStrategy and Funding, Waikato District Health Board, Hamilton, New Zealand"},{"name":"FCorresponding author. Email: Ross.Lawrenson@waikatodhb.health.nz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"12","key":"2025111818281412400_R1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","article-title":"The expanding role of primary care in cancer control.","volume":"16","author":"Rubin","year":"2015","journal-title":"Lancet Oncol."},{"issue":"7","key":"2025111818281412400_R2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2012.366","article-title":"Projections of cancer prevalence in the United Kingdom, 2010\u20132040.","volume":"107","author":"Maddams","year":"2012","journal-title":"Br J Cancer."},{"issue":"4","key":"2025111818281412400_R3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"1514","key":"2025111818281412400_R4","first-page":"49","article-title":"An estimate of limited duration cancer prevalence in New Zealand using \u2018big\u2019 data.","volume":"133","author":"Brewer","year":"2020","journal-title":"N Z Med J."},{"issue":"1","key":"2025111818281412400_R5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2296-15-94","article-title":"Health care needs of cancer survivors in general practice: a systematic review.","volume":"15","author":"Hoekstra","year":"2014","journal-title":"BMC Fam Pract."},{"issue":"40","key":"2025111818281412400_R6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jncimonographs\/lgq002","article-title":"The interface between primary and oncology specialty care: treatment through survivorship.","volume":"2010","author":"Grunfeld","year":"2010","journal-title":"J Natl Cancer Inst Monogr."},{"issue":"S1","key":"2025111818281412400_R7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/bjc.2011.416","article-title":"The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors.","volume":"105","author":"Richards","year":"2011","journal-title":"Br J Cancer."},{"key":"2025111818281412400_R8","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2146\/ajhp100078","article-title":"Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.","volume":"67","author":"Michaud","year":"2010","journal-title":"Am J Health Syst Pharm."},{"issue":"23","key":"2025111818281412400_R9","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","article-title":"Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study.","volume":"60","author":"Seicean","year":"2012","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"2025111818281412400_R10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.radonc.2017.03.012","article-title":"Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977\u20132005.","volume":"123","author":"Rehammar","year":"2017","journal-title":"Radiother Oncol."},{"issue":"4","key":"2025111818281412400_R11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","article-title":"Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.","volume":"126","author":"Louzada","year":"2012","journal-title":"Circulation."},{"issue":"9","key":"2025111818281412400_R12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.","volume":"63","author":"Beaugerie","year":"2014","journal-title":"Gut."},{"issue":"6","key":"2025111818281412400_R13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-4362.1996.tb03022.x","article-title":"Recurrent nonmelanoma skin cancer in Southern Australia.","volume":"35","author":"Czarnecki","year":"1996","journal-title":"Int J Dermatol."},{"issue":"15","key":"2025111818281412400_R14","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1200\/JCO.2005.03.1567","article-title":"Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care.","volume":"24","author":"Koroukian","year":"2006","journal-title":"J Clin Oncol."},{"key":"2025111818281412400_R15"},{"issue":"4","key":"2025111818281412400_R16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/cncr.28951","article-title":"Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II.","volume":"121","author":"Burg","year":"2015","journal-title":"Cancer."},{"issue":"1279","key":"2025111818281412400_R17","first-page":"27","article-title":"The road we travel: M\u0101ori experience of cancer.","volume":"121","author":"Walker","year":"2008","journal-title":"N Z Med J."},{"issue":"4","key":"2025111818281412400_R18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1071\/HC13308","article-title":"\u2018It\u2019s whanaungatanga and all that kind of stuff\u2019: Maori cancer patients\u2019 experiences of health services.","volume":"5","author":"Slater","year":"2013","journal-title":"J Prim Health Care."},{"issue":"1","key":"2025111818281412400_R19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12885-016-2781-4","article-title":"Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up.","volume":"16","author":"Teng","year":"2016","journal-title":"BMC Cancer."},{"issue":"1\u20132","key":"2025111818281412400_R20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/ans.12041","article-title":"Indigenous inequalities in cancer: what role for health care?","volume":"83","author":"Hill","year":"2013","journal-title":"ANZ J Surg."},{"issue":"6","key":"2025111818281412400_R21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.canep.2015.10.018","article-title":"Trends in ethnic and socioeconomic inequalities in cancer survival, New Zealand, 1991\u20132004.","volume":"39","author":"Soeberg","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"2025111818281412400_R22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12885-017-3797-0","article-title":"Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?","volume":"18","author":"Tin Tin","year":"2018","journal-title":"BMC Cancer."},{"key":"2025111818281412400_R23"},{"issue":"1","key":"2025111818281412400_R24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.24135\/tekaharoa.v7i1.51","article-title":"M\u0101ori health: issues relating to health care services.","volume":"7","author":"Elers","year":"2014","journal-title":"Te Kaharoa."},{"key":"2025111818281412400_R25","unstructured":"Ruhl J, Callaghna C, Hurlbut A, et al. Summary stage 2018: codes and coding instructions. Bethesda, MD. Available from: https:\/\/seer.cancer.gov\/tools\/ssm\/2018-Summary-Stage-Manual.pdf."},{"issue":"5","key":"2025111818281412400_R26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jclinepi.2013.11.012","article-title":"Cancer-specific administrative data\u2013based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices.","volume":"67","author":"Sarfati","year":"2014","journal-title":"J Clin Epidemiol."},{"key":"2025111818281412400_R27"},{"issue":"1","key":"2025111818281412400_R28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ajco.12062","article-title":"Cancer survival and prevalence in Australia: period estimates from 1982 to 2010.","volume":"9","author":"Australian Institute of Health and Welfare","year":"2013","journal-title":"Asia Pac J Clin Oncol."},{"issue":"1","key":"2025111818281412400_R29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/02813439408997052","article-title":"Cancer prevalence in Israeli family practice: The Cancer Research Group.","volume":"12","author":"Spenser","year":"1994","journal-title":"Scand J Prim Health Care."},{"key":"2025111818281412400_R30","unstructured":"Ministry of Health. Selected Cancer 2015, 2016, 2017. [cited 2019 October 10]. Available from: https:\/\/www.health.govt.nz\/publication\/selected-cancers-2015-2016-2017"},{"issue":"33","key":"2025111818281412400_R31","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1200\/JCO.2012.41.9101","article-title":"Determinants of increased primary health care use in cancer survivors.","volume":"30","author":"Heins","year":"2012","journal-title":"J Clin Oncol."},{"issue":"5","key":"2025111818281412400_R32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1370\/afm.1379","article-title":"Adult cancer survivors discuss follow-up in primary care:\u2018not what I want, but maybe what I need\u2019.","volume":"10","author":"Hudson","year":"2012","journal-title":"Ann Fam Med."},{"issue":"12","key":"2025111818281412400_R33","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s11606-011-1808-4","article-title":"Differences between primary care physicians\u2019 and oncologists\u2019 knowledge, attitudes and practices regarding the care of cancer survivors.","volume":"26","author":"Potosky","year":"2011","journal-title":"J Gen Intern Med."},{"issue":"1","key":"2025111818281412400_R34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12885-018-5169-9","article-title":"Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review.","volume":"19","author":"Cassim","year":"2019","journal-title":"BMC Cancer."},{"issue":"4","key":"2025111818281412400_R35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/fampra\/cmt001","article-title":"Patient perceptions of barriers to the early diagnosis of lung cancer and advice for health service improvement.","volume":"30","author":"Walton","year":"2013","journal-title":"Fam Pract."},{"issue":"1430","key":"2025111818281412400_R36","first-page":"29","article-title":"The role and potential of community-based cancer care for M\u0101ori in Aotearoa\/New Zealand.","volume":"129","author":"Slater","year":"2016","journal-title":"N Z Med J."},{"issue":"2","key":"2025111818281412400_R37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/jech.2008.083816","article-title":"Survival disparities in indigenous and non-indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors.","volume":"64","author":"Hill","year":"2010","journal-title":"J Epidemiol Community Health."},{"issue":"1320","key":"2025111818281412400_R38","first-page":"45","article-title":"The prevalence of colorectal adenomas in M\u0101ori and New Zealand Europeans parallels colorectal cancer rates.","volume":"123","author":"Dickson","year":"2010","journal-title":"N Z Med J."},{"issue":"2","key":"2025111818281412400_R39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1071\/HC10163","article-title":"A whanau ora approach to health care for Maori.","volume":"2","author":"Kidd","year":"2010","journal-title":"J Prim Health Care."},{"issue":"31","key":"2025111818281412400_R40","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1200\/JCO.2014.56.0086","article-title":"Four-week prevalence of mental disorders in patients with cancer across major tumor entities.","volume":"32","author":"Mehnert","year":"2014","journal-title":"J Clin Oncol."},{"issue":"2\u20133","key":"2025111818281412400_R41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age.","volume":"141","author":"Linden","year":"2012","journal-title":"J Affect Disord."},{"key":"2025111818281412400_R42","unstructured":"Ministry of Health. Cancer psychological and social support initiative. Wellington, NZ: Ministry of Health. [cited 2019 November 20]. Available from https:\/\/www.health.govt.nz\/our-work\/diseases-and-conditions\/national-cancer-programme\/cancer-initiatives\/cancer-psychological-and-social-support-initiative"},{"key":"2025111818281412400_R43","unstructured":"Ministry of Health. Obesity statistics. Wellington, NZ: Ministry of Health. [cited 2019 November 20]. Available from: https:\/\/www.health.govt.nz\/nz-health-statistics\/health-statistics-and-data-sets\/obesity-statistics"},{"key":"2025111818281412400_R44","unstructured":"Ministry of Health. Diabetes. Wellington, NZ: Ministry of Health. [cited 2019 November 20]. Available from: https:\/\/www.health.govt.nz\/our-work\/populations\/maori-health\/tatau-kahukura-maori-health-statistics\/nga-mana-hauora-tutohu-health-status-indicators\/diabetes"},{"issue":"4","key":"2025111818281412400_R45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report.","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin."}],"container-title":["The Journal of Primary Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/hc\/article-pdf\/12\/3\/215\/222960\/hc19113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/hc\/article-pdf\/12\/3\/215\/222960\/hc19113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:28:19Z","timestamp":1763508499000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/hc\/article\/12\/3\/215\/34961\/Prevalence-of-invasive-cancer-in-a-large-general"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,9]]},"published-print":{"date-parts":[[2020,9,29]]}},"URL":"https:\/\/doi.org\/10.1071\/hc19113","relation":{},"ISSN":["1172-6156"],"issn-type":[{"type":"electronic","value":"1172-6156"}],"subject":[],"published":{"date-parts":[[2020,9,9]]}}}